EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Astragalus polyphenols attenuates doxorubicin-induced cardiotoxicity by activating the PI3K/AKT/NRF2 pathway

Xueyang Bai, Hua Wei, Gangqiong Liu, Ling Li iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0319067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Xueyang Bai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Doxorubicin, Polyphenols, Cardiotoxicity. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Doxorubicin (DOX) is a powerful chemotherapeutic agent commonly employed in cancer treatment. However, its clinical utility is constrained by dose-dependent cardiotoxicity, which can result in heart failure and sudden cardiac death. The molecular mechanisms of DOX-induced cardiotoxicity (DIC) include oxidative stress, mitochondrial dysfunction, and the activation of cell death pathways, including ferroptosis. There is an urgent need for effective therapeutic strategies to mitigate DIC.

Methods

This study investigates the cardioprotective effects of Astragalus Polyphenols (ASP), a bioactive compound extracted from Astragalus membranaceus. In the context of DIC, we utilized AC16 and H9C2 cardiomyocytes to establish a DIC model and assessed the effects of ASP on cell viability, oxidative stress, mitochondrial function, and the PI3K/AKT/NRF2 signaling pathway. The expression of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), markers of cardiac injury, was also evaluated.

Results

ASP treatment significantly reversed DOX-induced reductions in cell viability and mitochondrial membrane potential (MMP) while also decreasing the levels of reactive oxygen species (ROS). Additionally, ASP also downregulated the expression of ANP and BNP, indicating a protective effect on cardiomyocytes. Furthermore, ASP activated the PI3K/AKT/NRF2 pathway, which was suppressed by DOX. Inhibition of this pathway using LY294002 and ML385 abolishes the protective effects of ASP, suggesting that ASP mediates its effects through the PI3K/AKT/NRF2 signaling axis.

Conclusion

ASP exhibits a protective effect against DOX-induced cardiotoxicity by regulating the PI3K/AKT/NRF2 pathway to reduce oxidative stress and preserve mitochondrial function. These findings suggest that ASP may serve as a potential therapeutic agent to alleviate DIC. Our results provide a novel strategy to protect the heart in patients undergoing DOX chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2DoxorubicinPolyphenolsCardiotoxicitySignal TransductionAstragalus PlantProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesAnimalsMyocytes, CardiacRatsOxidative StressCell LineCell SurvivalMembrane Potential, MitochondrialReactive Oxygen Species

Substanzen

NF-E2-Related Factor 2Proto-Oncogene Proteins c-aktDoxorubicinPhosphatidylinositol 3-KinasesPolyphenolsNfe2l2 protein, ratReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Department of Cardiology, Hami Central Hospital, Hami, Xinjiang, China.

ORCID-Profile: Ling Li

Zitieren

APA

Bai, X., Wei, H., Liu, G., & Li, L. (2025). Astragalus polyphenols attenuates doxorubicin-induced cardiotoxicity by activating the PI3K/AKT/NRF2 pathway. PLOS ONE. https://doi.org/10.1371/journal.pone.0319067

Vancouver

Bai X, Wei H, Liu G, Li L. Astragalus polyphenols attenuates doxorubicin-induced cardiotoxicity by activating the PI3K/AKT/NRF2 pathway. PLOS ONE. 2025. doi:10.1371/journal.pone.0319067

BibTeX
@article{Bai2025,
  author = {Bai, Xueyang and Wei, Hua and Liu, Gangqiong and Li, Ling},
  title = {Astragalus polyphenols attenuates doxorubicin-induced cardiotoxicity by activating the PI3K/AKT/NRF2 pathway},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0319067}
}
Kostenlos starten →